• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白激酶Cα mRNA在人肝细胞癌中的过表达:疾病预后的潜在标志物。

Overexpression of protein kinase C alpha mRNA in human hepatocellular carcinoma: a potential marker of disease prognosis.

作者信息

Wu Trang-Tiau, Hsieh Yi-Hsien, Wu Cheng-Chung, Hsieh Yih-Shou, Huang Chih-Yang, Liu Jer-Yuh

机构信息

Department of Surgery, School of Medicine, Medical College, Chung Shan Medical University, Taichung, Taiwan.

出版信息

Clin Chim Acta. 2007 Jul;382(1-2):54-8. doi: 10.1016/j.cca.2007.03.018. Epub 2007 Mar 28.

DOI:10.1016/j.cca.2007.03.018
PMID:17459358
Abstract

BACKGROUND

Members of the protein kinase C (PKC) isoenzyme family play a central role in the tumorigenesis of several tissues. However, little is known about subtype specific intracellular expression of PKC in human hepatocellular carcinomas.

METHODS

We investigated PKC isoforms mRNA expression in 42 HCC specimens using reverse transcription polymerase chain reaction analysis, and the correlation between PKC isoforms expression and clinicopathologic parameters.

RESULTS

We found that PKCalpha, PKCdelta and PKCiota mRNA were significantly increased in HCCs as compared to the corresponding non-cancerous liver tissues. PKCalpha expression also significantly correlated with tumor size (P<0.05) and TNM stage (P<0.05), but PKCdelta and PKCiota did not. The log-rank analysis revealed that patients with higher PKCalpha mRNA expression in the HCC tissues had significantly shorter survival rate than patients with lower PKCalpha mRNA expression (P<0.01).

CONCLUSIONS

Our results suggested that the PKCalpha may be a prognostic factor for the survival of patients with HCC.

摘要

背景

蛋白激酶C(PKC)同工酶家族成员在多种组织的肿瘤发生中起核心作用。然而,关于PKC在人类肝细胞癌中的亚型特异性细胞内表达情况知之甚少。

方法

我们采用逆转录聚合酶链反应分析方法,研究了42例肝癌标本中PKC亚型的mRNA表达情况,以及PKC亚型表达与临床病理参数之间的相关性。

结果

我们发现,与相应的非癌肝组织相比,肝癌组织中PKCα、PKCδ和PKCι的mRNA显著增加。PKCα的表达也与肿瘤大小(P<0.05)和TNM分期(P<0.05)显著相关,但PKCδ和PKCι与肿瘤大小和TNM分期无关。对数秩分析显示,肝癌组织中PKCα mRNA表达较高的患者生存率显著低于PKCα mRNA表达较低的患者(P<0.01)。

结论

我们的结果表明,PKCα可能是肝癌患者生存的一个预后因素。

相似文献

1
Overexpression of protein kinase C alpha mRNA in human hepatocellular carcinoma: a potential marker of disease prognosis.蛋白激酶Cα mRNA在人肝细胞癌中的过表达:疾病预后的潜在标志物。
Clin Chim Acta. 2007 Jul;382(1-2):54-8. doi: 10.1016/j.cca.2007.03.018. Epub 2007 Mar 28.
2
Overexpression of protein kinase Calpha mRNA may be an independent prognostic marker for gastric carcinoma.蛋白激酶Cα信使核糖核酸的过表达可能是胃癌的一个独立预后标志物。
J Surg Oncol. 2008 May 1;97(6):538-43. doi: 10.1002/jso.20997.
3
Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor.粘着斑激酶在肝细胞癌中过表达,可作为独立的预后因素。
J Hepatol. 2004 Jul;41(1):104-11. doi: 10.1016/j.jhep.2004.03.029.
4
Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.威斯科特-奥尔德里奇综合征蛋白家族维普洛林同源蛋白2表达增加与肝细胞癌预后不良相关。
Clin Cancer Res. 2006 Oct 1;12(19):5673-9. doi: 10.1158/1078-0432.CCR-06-0022.
5
Protein kinase C isoform expression in ovarian carcinoma correlates with indicators of poor prognosis.蛋白激酶C亚型在卵巢癌中的表达与预后不良指标相关。
Int J Oncol. 2003 Sep;23(3):633-9.
6
[Focal adhesion kinase mRNA overexpression in hepatocellular carcinoma HCC) and correlation thereof with prognosis of HCC].[肝细胞癌中粘着斑激酶mRNA的过表达及其与肝细胞癌预后的相关性]
Zhonghua Yi Xue Za Zhi. 2007 May 15;87(18):1256-9.
7
Detection of a unique gamma-glutamyl transpeptidase messenger RNA species closely related to the development of hepatocellular carcinoma in humans: a new candidate for early diagnosis of hepatocellular carcinoma.与人类肝细胞癌发生密切相关的一种独特γ-谷氨酰转肽酶信使核糖核酸的检测:肝细胞癌早期诊断的新候选指标
Hepatology. 1996 May;23(5):1093-7. doi: 10.1002/hep.510230524.
8
[Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].[基质金属蛋白酶及其组织抑制剂在肝细胞癌中的表达]
Hunan Yi Ke Da Xue Xue Bao. 2003 Jun;28(3):212-6.
9
The tumor suppressor NPRL2 in hepatocellular carcinoma plays an important role in progression and can be served as an independent prognostic factor.肿瘤抑制因子NPRL2在肝细胞癌的进展中起重要作用,可作为独立的预后因素。
J Surg Oncol. 2009 Oct 1;100(5):358-63. doi: 10.1002/jso.21241.
10
Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.骨桥蛋白的过表达与肝内转移、早期复发以及手术切除的肝细胞癌预后较差有关。
Cancer. 2003 Jul 1;98(1):119-27. doi: 10.1002/cncr.11487.

引用本文的文献

1
Protein Kinase C Delta Is a Novel Biomarker for Hepatocellular Carcinoma.蛋白激酶Cδ是肝细胞癌的一种新型生物标志物。
Gastro Hep Adv. 2022 Aug 5;2(1):83-95. doi: 10.1016/j.gastha.2022.07.020. eCollection 2023.
2
Inhibition of protein kinase C delta leads to cellular senescence to induce anti-tumor effects in colorectal cancer.蛋白激酶 C 亚型 δ 的抑制可导致细胞衰老,从而在结直肠癌中发挥抗肿瘤作用。
Cancer Sci. 2023 Jun;114(6):2471-2484. doi: 10.1111/cas.15768. Epub 2023 Mar 14.
3
Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer.
蛋白激酶C(PKC)同工酶作为癌症的诊断和预后生物标志物及治疗靶点
Cancers (Basel). 2022 Nov 3;14(21):5425. doi: 10.3390/cancers14215425.
4
The complexities of PKCα signaling in cancer.PKCα 信号在癌症中的复杂性。
Adv Biol Regul. 2021 May;80:100769. doi: 10.1016/j.jbior.2020.100769. Epub 2020 Nov 23.
5
MZF-1/Elk-1/PKCα is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma.MZF-1/Elk-1/PKCα与肝细胞癌患者的不良预后相关。
J Cancer. 2017 Sep 2;8(15):3028-3036. doi: 10.7150/jca.20467. eCollection 2017.
6
Inhibition of protein kinase C by isojacareubin suppresses hepatocellular carcinoma metastasis and induces apoptosis in vitro and in vivo.异巴西红厚壳素对蛋白激酶C的抑制作用可抑制肝癌转移,并在体外和体内诱导细胞凋亡。
Sci Rep. 2015 Aug 6;5:12889. doi: 10.1038/srep12889.
7
MZF-1/Elk-1 Complex Binds to Protein Kinase Cα Promoter and Is Involved in Hepatocellular Carcinoma.MZF-1/Elk-1复合物与蛋白激酶Cα启动子结合并参与肝细胞癌的发生。
PLoS One. 2015 May 26;10(5):e0127420. doi: 10.1371/journal.pone.0127420. eCollection 2015.
8
Prostaglandin E2 stimulates β1-integrin expression in hepatocellular carcinoma through the EP1 receptor/PKC/NF-κB pathway.前列腺素E2通过EP1受体/蛋白激酶C/核因子κB途径刺激肝细胞癌中β1整合素的表达。
Sci Rep. 2014 Oct 7;4:6538. doi: 10.1038/srep06538.
9
Low PKCα expression within the MRD-HR stratum defines a new subgroup of childhood T-ALL with very poor outcome.微小残留病高危(MRD-HR)组内蛋白激酶Cα(PKCα)低表达定义了一个预后极差的儿童T细胞急性淋巴细胞白血病新亚组。
Oncotarget. 2014 Jul 30;5(14):5234-45. doi: 10.18632/oncotarget.2062.
10
β-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma.一种新型肝祖细胞中的β-连环蛋白激活足以引发肝细胞癌和肝母细胞瘤。
Cancer Res. 2014 Aug 15;74(16):4515-25. doi: 10.1158/0008-5472.CAN-13-3275. Epub 2014 May 21.